Validity of cytology in the diagnosis of small cell lung carcinoma

Živko Krivokuća; Željka Tatomirović; Gordana Cvetković; Jelena Džambas; Vesna Škuletic; Saša Ristić

doi:10.2298/VSP180813172K

Živko Krivokuća University of Defence, Faculty of Medicine of the Military Medical Academy, Belgrade, Serbia
Željka Tatomirović University of Defence, Faculty of Medicine of the Military Medical Academy, Belgrade, Serbia
Gordana Cvetković University of Defence, Faculty of Medicine of the Military Medical Academy, Belgrade, Serbia
Jelena Džambas Military Medical Academy, Institute of Pathology and Forensic Medicine, Belgrade, Serbia
Vesna Škuletic University of Defence, Faculty of Medicine of the Military Medical Academy, Belgrade, Serbia
Saša Ristić Military Medical Academy, Institute of Pathology and Forensic Medicine, Belgrade, Serbia

DOI: https://doi.org/10.2298/VSP180813172K

Keywords: bronchoscopy, carcinoma, non-small-cell lung, cytological techniques, diagnosis, diagnosis, differential, histological techniques, small cell lung carcinoma

Abstract

Background/Aim. Small cell lung carcinoma (SCLC) is the most aggressive form of lung cancer. Patients with SCLC generally appear in a locally advanced or disseminated stage, when small biopsies and/or cytological materials are the only possibility for diagnosis. The aim of this study was to evaluate the validity of cytology in the initial diagnosis of SCLC, comparing cytological with histological findings of small biopsies. Methods. The retrospective study included 200 patients with cytological diagnosis of SCLC, established in the period from 2016 to 2018 based on examination of the exfoliative material (sputum), as well as abrasive and aspiration materials obtained during bronchoscopy. In the same act, bronchoscopic materials were taken for cytological and histological diagnosis. Cytological materials were stained by May Grünwald Giemsa and histological ones using hematoxylin-eosin and immunohistochemical stains. Results. The most frequently sampled materials were: transbronchial needle aspiration (TBNA) in 72.2% of the patients and bronchial brushing in 18.54% of the patients, in the following order: bronchial aspirate in 4.88%, tru-cut needle biopsy in 5.37%, and sputum in 2.44% of the patients. In 91.5% (183/200) of the patients cytological diagnosis of SCLC was histopathologically confirmed. Among 17 patients whose cytological diagnosis of SCLC was not confirmed histopathologically, another type of tumor was histopathologically proved for 12 (6%) of them: in 6 cases non SCLC not otherwise specified, and in each per one squamocellular carcinoma, adenocarcinoma, large cell carcinoma, mixed tumor (NSCLC with a neuroendocrine component), lymphoma and sarcoma. Finally, in five patients histological material was false-negative. Conclusion. Cytological diagnosis of SCLC is a reliable method which yields satisfactory accuracy. The best way is to be interpreted in conjunction with histology of small biopsies. When only cytological materials are available, in doubtful cases, other small round cell tumors, and poorly differentiated NSCLC, must be considered in the differential diagnosis.

Author Biography

Živko Krivokuća, University of Defence, Faculty of Medicine of the Military Medical Academy, Belgrade, Serbia

Srbija

References

World Health Organization Media Centre. Cancer. Fact Sheet No. 297. Available from: http://www.who.int/mediacentre/ factsheets/fs297/en/[accessed: 2017 October 5].

Ganjei-Azar p, Jorda M. 14 Cytologic Sub-Classificatiom of Lung Cancer: A New Challenge for Practicing Pathologists. Las Vegas, NV; Annual Meeting 2011; Chicago, IL: American Society for Clinical Pathology; 2011.

Institut za javno zdravlјe Srbije “Dr Milan Jovanović Batut”. Zdravstveno-statistički godišnjak Republike Srbije, 2015; [cit-ed 2017 Aug 22]. Available from: http://www.batut.org.rs/

Znaor A, van den Hurk C, Primic-Zakelj M, Agius D, Coza D, Demetriou A, et al. Cancer incidence and mortality patterns I n South Eastern Europe in the last decade: gaps persist com-pared with the rest of Europe. Eur J Cancer 2013; 49(7): 1683–91.

Ahn HD, Gerber ED. Lung cancer etiology, epidemiology and risk factors. In: Ganti KA, Gerber ED, editors. Lung cancer. 1st ed. New York: Oxford University Press; 2013. p. 1–11.

PDQ Adult Treatment Editorial Board. Small Cell Lung Can-cer Treatment (PDQ®): Health Professional Version. [ac-cessed 2018 Feb 9]. PDQ Cancer Information Summaries [In-ternet]. Bethesda (MD): National Cancer Institute (US); 2002. Available from: http://www.ncbi.nlm.nih.gov/books/NBK65909/

Thunnissen E, Unger M, Flieder DB. Chapter 24. Epidemiologi-cal and clinical aspects of lung cancer. In: Haslteton P, Flieder BD, editors. Spencer’s pathology of the lung. 6th ed. New York, NY: Cambridge University Press; 2013. p. 945–1003.

Larsen JE, Minna JD. Molecular biology of lung cancer: clinical implications. Clin Cnest Мed 2011; 32(4): 703‒40.

Domagała-Kulawik J, Górnicka B, Krenke R, Mich S, Chazan R. The value of cytological diagnosis of small cell lung carcinoma. Pneumonol Alergol Pol 2010; 78(3): 203–10.

Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger K, Yatabe Y, et al. Diagnosis of lung cancer in small biopsies and cytology: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Socie-ty/European Respiratory Society classification. Arch Pathol Lab Med 2013; 137(5): 668–84.

Byers LA, Rudin CM. Small cell lung cancer: where do we go from here? Cancer 2015; 121(5): 664–72.

Tsoukalas N, Aravantinou-Fatorou E, Baxevanos P, Tolia M, Tsapakidis K, Galanopoulos M, et al. Advanced small cell lung cancer (SCLC): new challenges and new expectations. Ann Transl Med 2018; 6(8): 145.

Hasleton P, Flieder DB. Spencer's pathology of the lung. 6th ed. New York (NY): Cambridge University Press; 2013.

Rosai J. Lung and pleura: Small cell carcinoma. 10th ed. In: Rosai J, editor. Rosai and Ackerman's Surgical Pathology. New York, NY: Mosby; 2011. p. 377–9.

Winston WE, Karim NA. Small Cell Lung Cancer. [updated 2018 May 29]. Available from: https://emedicine.medscape.com/article/280104

Nisholson SA, Beasley MB, Brambilla E, Hasleton PS, Colby TV, Sheppard MN, et al. Small cell lung carcinoma (SCLC): a clini-copathologic study of 100 ceses with surgical apecimens. Am J Surg Pathol 2002; 26(9): 1184–97.

Travis WD, Brambilla E, Nicholson AG, Yatabe Y, Austin JHM, Beasley MB, et al. WHO Panel. The 2015 World Health Or-ganization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classifica-tion. J Thorac Oncol 2015; 10(9): 1243–60.

French AC. Respiratory tract and mediastinum. In: Cibas E, Ducatman B, editors. Cytology: diagnostic principles and clini-cal correlates. 4th ed. Philadelphia: WB Saunders; 2014. p. 79–95.

Delgado PI, Jorda M, Ganjei-Azar P. Small cell carcinomaversus other lung malignancies: diagnosis by fine-needle aspiration cy-tology. Cancer 2000; 90(5): 279–85.

Proietti A, Boldrini L, Ali G, Servadio A, Lupi C, Sensi E, et al. Histo-cytological diagnostic accuracy in lung vancer. Cyto-pathology 2014; 25(6): 404–11.

Rivera MP, Mehta AC. Initial diagnosis of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007; 132(3 Suppl): 131S–48S.

Cuffe S, Moua T, Summerfield R, Roberts H, Jett J, Shepherd FA. Characteristics and outcomes of small cell lung cancer patients diagnosed during two lung cancer computed tomographic screening programs in heavy smokers. J Thorac Oncol 2011; 6(4): 818–22.

Li WN, Wang DF, Yhao YB, Qiu XS, Wang EH, Wu GP. Comparative analysis for duiagnostic yield of small cell lung cancer by cytology and histology during the same bronhoscop-ic procedure. Clin Lung Cancer 2017; 18(5): e357–61.

Miličić V, Prvulović I, Mišuiić M, Perić M, Samardžić S, Tomić K. Value of cytology in small cell lung carcinoma diagnostic – single center study. Coll Antropol 2014; 38(2): 611–6.

Strimpakos A, Politi E, Kainis E, Grapsa D, Siolos S, Tsagouli S, et al. The clinical significance of cytology versus histology-based diagnosis in small cell lung cancer: a retrospective study. Lung Cancer 2014; 85(2): 186–90.

Sakr L, Roll P, Payan MJ, Liprandi A, Dutau H, Astoul P, et al. Cytology-based treatment decision in primary lung cancer: is it accurate enough? Lung Cancer 2012; 75(3): 293–9.

Renshaw AA, Voytek TM, Haja J, Wilbur DC. Cytology Com-mittee, College of American Pathologists. Distinguishing small cell carcinoma from non-small cell carcinoma of the lung: cor-relating cytologic features and performance in the College of American Pathologists Non-Gynecologic Cytology Program. Arch Pathol Lab Med 2005; 129(5): 619–23.

Sturgis CD, Nassar DL, D`Antonio JA, Raab S. Cytologic fea-tures useful for distinguishing small cell from non.small cell carcinoma in bronchial brush and wash specimens. Am J Clin pathol 2000; 114(2): 197–202.

Vollmer RT, Ogden L, Crissman JD. Separation of small-cell from non-small-cell lung cancer. The Southeastern Cancer Study Group pathologists' experience. Arch Pathol Lab Med 1984; 108(10): 792–4.

Travis WD. Update on small cell carcinoma and its differentia-tion from squamous cell carcinoma and other non-small cell carcinomas. Mod Pathol 2012; 25(Suppl 1): S18–30.

DeMay RM. Soft-tissue tumors. In: DeMay RM, editor. The art and science of cytopathology. 1st ed. Chicago: ASCP Press; 1996. p. 559–642.